Immunotherapy for Pediatric Cancer
CAR T-cell therapy is a promising new treatment for some of the most challenging cases faced in pediatric cancers. During this course, participants will become familiar with current T-cell therapy approaches. Dr. Gottschalk will also explain how T-cells are generated and used in clinical settings.
Pediatricians, Pediatric Oncologists, Hematologists/Oncologists, Infectious Disease Pediatricians, Pediatric General Internists, Family Physicians, Neonatologists, ED Physicians, Physician Assistants, Nurses, Advanced Practice Registered Nurses, Respiratory Therapists (Personal Growth) and all other interested healthcare providers who care for children with cancer.
- Implement immune-based therapies underlying target selection.
- Assess the potential of implementing tumor-specific translocations.
Stephen Gottschalk, M.D.
Chair, Department of Bone Marrow Transplantation and Cellular Therapy
Endowed Chair in Bone Marrow Transplantation and Cellular Therapy
St. Jude’s Children’s Hospital
Stephen Gottshalk, M.D., faculty for this educational activity, has indicated that he has patents and patent applications in the fields of T-cell and gene therapy for cancer, has a research collaboration with TESSA Therapeutics, is a DSMB/SAB member for Immatics and Tidal and has been a consultant for Merck, Allovir and PACT and has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Doured Daghistani, M.D.
Baptist, Homestead and South Miami Hospitals
Doured Daghistani, M.D., conference director of this educational activity, has no relevant financial relationship to disclose with ineligible companies.*
Ziad Khatib, M.D.
Director of Medical Neuro-Oncology
Division of Pediatric Hematology/Oncology
Clinical Associate Professor
Department of Pediatrics
Florida International University
Kidz Medical Services
Nicklaus Children’s Hospital
Ziad Khatib, M.D., conference director of this educational activity, has no relevant financial relationship to disclose with ineligible companies.*
All of the relevant financial relationships listed for these individuals has been mitigated.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies -- Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Respiratory Therapy
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.